MedPath

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

🇸🇬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

167

HSA:167

Drug Approvals

TERIPARATIDE-TEVA SOLUTION FOR INJECTION IN PRE-FILLED PEN 20 MCG/80 MCL

Approval Date
Sep 10, 2024
HSA

LENALIDOMIDE-TEVA CAPSULE 10mg

Approval Date
May 17, 2024
HSA

LENALIDOMIDE-TEVA CAPSULE 15mg

Approval Date
May 17, 2024
HSA

LENALIDOMIDE-TEVA CAPSULE 5mg

Approval Date
May 17, 2024
HSA

PAZOPANIB-TEVA FC TABLETS 200 MG

Approval Date
May 8, 2024
HSA

ABIRATERONE-TEVA FC TABLET 500 MG

Approval Date
Apr 18, 2024
HSA

LOSARTAN-TEVA FC TABLET 100MG

Approval Date
Mar 22, 2024
HSA

LOSARTAN-TEVA FC TABLET 50MG

Approval Date
Mar 22, 2024
HSA

SUGAMMADEX-TEVA SOLUTION FOR INJECTION 100MG/ML

Approval Date
Feb 26, 2024
HSA

TADALAFIL-TEVA FC TABLET 20MG

Approval Date
Oct 13, 2023
HSA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 17
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.